To explore the potential involvement of GPN3 in the progression of NSCLC, we initially examined the expression level of GPN3 in two major NSCLC subtypes, namely LUAD and LUSC, utilizing the TCGA database through UALCAN analysis platform [26]. This evidence concerns the gene GPN3 and non-small cell lung carcinoma.